← 產業報告目錄
India and Oman Pharmaceutical Industry Market, By Drug (Generic, Patented (Branded)), By Type (Prescription Drugs, Over the Counter Drugs), By Drug Class (Analgesics, Anesthetics, Antibacterials, Antidepressants, Corticosteroids, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Anticonvulsants, Antivirals, Anticoagulants, ACE inhibitors, Hormonal agents, Insulin, Contraceptives, Diuretics, Vaccines, Others), By Application (Cardiovascular (Ischemic Heart Disease, Others), Hypertension, Musculoskeletal, Oncology, Anti-infective, Cirrhosis, Metabolic Disorder(Diabetes, Others), Weight Management, Central Nervous System, Genito-urinary, Kidney Disease, Gastrointestinal, Respiratory, Hematology, Dermatology, Ophthalmology, Others (Nutraceutical, Dentals, and Gynecology)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (India and Oman)
出版商 Coherent Market Insights出版日期 2026-07-08頁數 256報告編號 CMR-68944cd847
授權報價
| Single User Price | $4,500 USD |
| Site License Price | $7,000 USD |
| Enterprisewide Price (Global Site License) | $10,000 USD |
報告摘要
The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition, and patent cliffs. Innovation is of vital importance for steady growth of key market players. They have been mainly dependent on a few blockbuster molecules. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex. This is influencing players offering complementary products and services to collaborate for new product development. Moreover, key market players are investing in consumer health products, with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging the key market players to enter the OTC market and leverage their brand equity among the doctors, chemists, and consumers.
Market Dynamics
The increasing prevalence of chronic diseases such as diabetes, cancer, cardiovascular disease, chronic kidney diseases, and others is expected to drive the growth of Oman pharmaceutical industry market over the forecast period. For instance, according to the World Health Organization 2018 report, in 2018, coronary heart disease deaths in Oman reached 2,904 or 28.23% of total deaths. The age adjusted death rate is 179.48 per 100,000 population, which ranks Oman at 45th position in the world in coronary heart disease patient population. Moreover, according to the World Health Organization (WHO), chronic kidney disease (CKD) is the sixth main cause of death in Oman, with a rate of 18.10 per 100,000 population (2.97% of total deaths) every year caused due to CKD in Oman. Similarly, Oman was ranked 51st among the top world countries in which CKD is a major cause of death.
Key features of the study
• This report provides in-depth analysis of the India & Oman pharmaceutical industry market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the India & Oman pharmaceutical industry market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies
• Key companies covered as a part of this study include Pfizer, Inc., Bristol Myers Squibb, Sanofi S.A., F. Hoffmann-La Roche AG, Bayer AG, Novartis International AG, Merck & Co., Inc., AbbVie, GlaxoSmithKline plc, Eli Lilly and Company, Zydus Cadila, Aurobindo Pharma Ltd., Cipla Ltd., Dr. Reddy's Laboratories Ltd., Lupin Ltd., Sun Pharmaceutical Industries Limited, Serum Institute of India Pvt. Ltd., Biocon Limited, Strides Pharma Science Limited, and Unichem Laboratories
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The India & Oman pharmaceutical industry market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the India & Oman pharmaceutical industry market
Market Segmentation
• By Drug Insights (Revenue, USD Mn, 2021 - 2033)
o Generic
o Patented (Branded)
• By Type Insights (Revenue, USD Mn, 2021 - 2033)
o Prescription Drugs
o Over the Counter Drugs
• By Drug Class Insights (Revenue, USD Mn, 2021 - 2033)
o Analgesics
o Anesthetics
o Antibacterials
o Antidepressants
o Corticosteroids
o Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
o Anticonvulsants
o Antivirals
o Anticoagulants
o ACE inhibitors
o Hormonal agents
o Insulin
o Contraceptives
o Diuretics
o Vaccines
o Others
• By Application Insights (Revenue, USD Mn, 2021 - 2033)
o Cardiovascular
Ischemic Heart Disease
Others
o Hypertension
o Musculoskeletal
o Oncology
o Anti-infective
o Cirrhosis
o Metabolic Disorder
Diabetes
Others
o Weight Management
o Central Nervous System
o Genito-urinary
o Kidney Disease
o Gastrointestinal
o Respiratory
o Hematology
o Dermatology
o Ophthalmology
o Others (Nutraceutical, Dentals, and Gynecology)
• By Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Region Insights (Revenue, USD Mn, 2021 - 2033)
o India
o Oman
• Key Players in the India and Oman Pharmaceutical Industry Market
o Pfizer, Inc.
o Bristol Myers Squibb
o Sanofi S.A.
o Hoffmann-La Roche AG
o Bayer AG
o Novartis International AG
o Merck & Co., Inc.
o AbbVie
o GlaxoSmithKline plc
o Eli Lilly and Company
o Zydus Cadila
o Aurobindo Pharma Ltd.
o Cipla Ltd.
o Reddy's Laboratories Ltd.
o Lupin Ltd.
o Sun Pharmaceutical Industries Limited
o Serum Institute of India Pvt. Ltd.
o Biocon Limited
o Strides Pharma Science Limited
o Unichem Laboratories
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Drug
Market Snapshot, By Type
Market Snapshot, By Drug Class
Market Snapshot, By Application
Market Snapshot, By Distribution Channel
Market Snapshot, By Country
Market Opportunity Map
3. India and Oman Pharmaceutical Industry Market
o Analysis of the Indian Pharmaceutical Industry
Drivers & Restraints
Market Opportunity
Market Trends
Impact Analysis
Mergers and Acquisitions
Epidemiology
PEST Analysis
SWOT Analysis
Regulatory Scenario
Reimbursement Scenario
Major Indian Exporters/Manufacturers (Global)
Major Indian Importers
Major Indian Exporters/Manufacturers (To Oman)
Indian Pharmaceutical Drugs Import Market
Indian Pharmaceutical Drugs Export Market
o Indian Pharmaceutical Drugs Export to Oman Market
4. Analysis of the Oman Pharmaceutical Industry
o Drivers & Restraints
o Market Opportunity
o Market Trends
o Impact Analysis
o Mergers and Acquisitions
o Epidemiology
o PEST Analysis
o SWOT Analysis
o Regulatory Scenario
o Industry Regulations
Trade Regulations and Procedures For Export to Oman
Trade Barriers (Tariff, Non-tariff, etc.) and Other Entry-level Barriers for Indian Pharma Products in Oman
o Reimbursement Scenario
o Major Oman Exporters/Manufacturers (Global)
o Major Oman Importers
o Strategy For Indian Pharma Products In Oman
o India's Strategy For Effectively Entering Oman Pharma Market
o USP Of Indian Companies In The Oman Pharmaceutical Market And Positioning Strategy
o Oman Pharmaceutical Drugs Import Market
o Oman Pharmaceutical Drugs Export Market
Oman Pharmaceutical Drugs Export to India Market
o Ayurvedic Drugs Market
Overview of Indian Ayurvedic Drugs
Ayurvedic Products by Indian Companies With Certification of Pharmaceutical Product (COPP) Granted As Per WHO-GMP Certification Scheme (1/2)
Overview of Oman Ayurvedic Drugs Import
Indian Ayurvedic Companies Registered in Oman
o Strategies Adopted By Local Oman Manufacturers
5. India and Oman Pharmaceutical Industry Market, By Drug, 2021 – 2033 (USD Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Generic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Patented (Branded)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
6. India and Oman Pharmaceutical Industry Market, By Type, 2021 – 2033 (USD Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Prescription Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Over the Counter Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million
7. India and Oman Pharmaceutical Industry Market, By Drug Class, 2021 – 2033 (USD Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Analgesics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Anesthetics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Antibacterials
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Antidepressants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Corticosteroids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Anticonvulsants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Antivirals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Anticoagulants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o ACE inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Hormonal agents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Insulin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Contraceptives
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Diuretics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
8. India and Oman Pharmaceutical Industry Market, By Application, 2021 – 2033 (USD Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Cardiovascular
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Ischemic Heart Disease
o Others
o Hypertension
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Musculoskeletal
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Anti-infective
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Metabolic Disorder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Diabetes
o Others
o Weight Management
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Central Nervous System
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Genito-urinary
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Kidney Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Gastrointestinal
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Respiratory
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Hematology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Dermatology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Ophthalmology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Others (Nutraceutical, Dentals, and Gynecology)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
9. India and Oman Pharmaceutical Industry Market, By Distribution Channel, 2021 – 2033 (USD Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033 (USD Million)
10. India and Oman Pharmaceutical Industry Market, By Country, 2021 – 2033 (USD Million)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Regional Trends
o India
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 – 2033 (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 – 2033 (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 – 2033 (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 – 2033 (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033 (USD Million)
o Oman
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 – 2033 (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 – 2033 (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2021 – 2033 (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 – 2033 (USD Million)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 – 2033 (USD Million)
11. Case Study of Successful Foreign Pharma Product Entries Into Oman Market
o Case Study of 5 Successful Foreign Pharma Companies Entry Into Oman Market
o Company Profiles (Global)
Pfizer, Inc.
o Company Highlights
o Products Portfolio
o Key Highlights
o Financial Performance
o SWOT Analysis
o Strategies
Bristol-Myers Squibb Company
o Company Highlights
o Products Portfolio
o Key Highlights
o Financial Performance
o SWOT Analysis
o Strategies
Sanofi S.A.
o Company Highlights
o Products Portfolio
o Key Highlights
o Financial Performance
o SWOT Analysis
o Strategies
F. Hoffmann-La Roche AG
o Company Highlights
o Products Portfolio
o Key Highlights
o Financial Performance
o SWOT Analysis
o Strategies
Bayer AG
o Company Highlights
o Products Portfolio
o Key Highlights
o Financial Performance
o SWOT Analysis
o Strategies
Novartis International AG
o Company Highlights
o Products Portfolio
o Key Highlights
o Financial Performance
o SWOT Analysis
o Strategies
Merck & Co., Inc.
o Company Highlights
o Products Portfolio
o Key Highlights
o Financial Performance
o SWOT Analysis
o Strategies
AbbVie Inc.
o Company Highlights
o Products Portfolio
o Key Highlights
o Financial Performance
o SWOT Analysis
o Strategies
GlaxoSmithKline plc.
o Company Highlights
o Products Portfolio
o Key Highlights
o Financial Performance
o SWOT Analysis
o Strategies
Eli Lilly and Company
o Company Highlights
o Products Portfolio
o Key Highlights
o Financial Performance
o SWOT Analysis
o Strategies
Zydus Cadila
o Company Highlights
o Products Portfolio
o Key Highlights
o Financial Performance
o SWOT Analysis
o Strategies
Aurobindo Pharma Ltd.
o Company Highlights
o Products Portfolio
o Key Highlights
o Financial Performance
o SWOT Analysis
o Strategies
Cipla Inc.
o Company Highlights
o Products Portfolio
o Key Highlights
o Financial Performance
o SWOT Analysis
o Strategies
Dr. Reddy's Laboratories Ltd.
o Company Highlights
o Products Portfolio
o Key Highlights
o Financial Performance
o SWOT Analysis
o Strategies
Lupin Ltd.
o Company Highlights
o Products Portfolio
o Key Highlights
o Financial Performance
o SWOT Analysis
o Strategies
Sun Pharmaceutical Industries Limited
o Company Highlights
o Products Portfolio
o Key Highlights
o Financial Performance
o SWOT Analysis
o Strategies
Serum Institute of India Pvt. Ltd.
o Company Highlights
o Products Portfolio
o Key Highlights
o Financial Performance
o SWOT Analysis
o Strategies
Biocon Limited
o Company Highlights
o Products Portfolio
o Key Highlights
o Financial Performance
o SWOT Analysis
o Strategies
Strides Pharma Science Limited
o Company Highlights
o Products Portfolio
o Key Highlights
o Financial Performance
o SWOT Analysis
o Strategies
Unichem Laboratories Limited
o Company Highlights
o Products Portfolio
o Key Highlights
o Financial Performance
o SWOT Analysis
o Strategies
12. Section
o Research Methodology
o About us
圖表清單 List of Tables & Figures
NA
NA
提及公司
o PfizerInc.o Bristol Myers Squibbo Sanofi S.A.o Hoffmann-La Roche AGo Bayer AGo Novartis International AGo Merck & Co.Inc.o AbbVieo GlaxoSmithKline plco Eli Lilly and Companyo Zydus Cadilao Aurobindo Pharma Ltd.o Cipla Ltd.o Reddy's Laboratories Ltd.o Lupin Ltd.o Sun Pharmaceutical Industries Limitedo Serum Institute of India Pvt. Ltd.o Biocon Limitedo Strides Pharma Science Limitedo Unichem Laboratories
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們